From: GRB7 plays a promoting role in the progression of gastric cancer
Features | No. of patients | GRB7 expression | p value | |
---|---|---|---|---|
low | high | |||
All patients | 86 | 38 | 48 | Â |
Age (years) | Â | Â | Â | 0.006 |
 ≤ 64 | 40 | 24 | 16 |  |
 > 64 | 46 | 14 | 32 |  |
Gender | Â | Â | Â | 0.772 |
 Male | 58 | 25 | 33 |  |
 Female | 28 | 13 | 15 |  |
T Infiltrate | Â | Â | Â | 0.012 |
 T1 | 5 | 4 | 1 |  |
 T2 | 11 | 5 | 6 |  |
 T3 | 49 | 25 | 24 |  |
 T4 | 21 | 4 | 17 |  |
Lymphatic metastasis (N) | Â | Â | Â | 0.814 |
 N0 | 16 | 6 | 10 |  |
 N1 | 15 | 10 | 5 |  |
 N2 | 16 | 5 | 11 |  |
 N3 | 39 | 17 | 22 |  |
Stage | Â | Â | Â | 0.163 |
 I | 7 | 4 | 3 |  |
 II | 25 | 13 | 12 |  |
 III | 53 | 21 | 32 |  |
 IV | 1 | 0 | 1 |  |
Number of lymph node metastases | Â | Â | Â | 0.360 |
 ≤ 6 | 45 | 22 | 23 |  |
 > 6 | 41 | 16 | 25 |  |